HY-P7673-100ug
|
MedChemexpress LLC
|
BST2, Human (HEK293, His)
|
|
|
|
HY-P7673-5ug
|
MedChemexpress LLC
|
BST2, Human (HEK293, His)
|
|
|
|
HY-P7673-50ug
|
MedChemexpress LLC
|
BST2, Human (HEK293, His)
|
|
|
|
HY-P7673-500ug
|
MedChemexpress LLC
|
BST2, Human (HEK293, His)
|
|
|
|
HY-153367-1mg
|
MedChemexpress LLC
|
FHD-609 [CAS 2676211-64-4]
|
|
Cancer-programmed cell death
|
|
HY-153367-10mg
|
MedChemexpress LLC
|
FHD-609 [CAS 2676211-64-4]
|
|
Cancer-programmed cell death
|
|
HY-153367-25mg
|
MedChemexpress LLC
|
FHD-609 [CAS 2676211-64-4]
|
|
Cancer-programmed cell death
|
|
HY-153367-5mg
|
MedChemexpress LLC
|
FHD-609 [CAS 2676211-64-4]
|
|
Cancer-programmed cell death
|
|
HY-153367-1mL
|
MedChemexpress LLC
|
FHD-609 [CAS 2676211-64-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P72800-10ug
|
MedChemexpress LLC
|
HA/Hemagglutinin, H1N1 (sf9, His)
|
|
|
|
HY-P72800-100ug
|
MedChemexpress LLC
|
HA/Hemagglutinin, H1N1 (sf9, His)
|
|
|
|
HY-P72800-50ug
|
MedChemexpress LLC
|
HA/Hemagglutinin, H1N1 (sf9, His)
|
|
|
|